The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Obstructive sleep apnea is a sleep disorder that causes your breathing to stop and start during the night. This can lead to loud snoring, disrupted rest and daytime fatigue, among other symptoms.

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...

About 30 million people suffer from sleep apnea in the US, Troxel told Fox News Digital. The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly drug initially developed as a treatment for ...

Treatment for anxiety can include talk therapy, medication, and relaxation techniques. People with both sleep apnea and anxiety should also practice good sleep habits, such as establishing a ...

“This is the first pharmacologic therapy that can treat obstructive ... type of sleep apnea known as obstructive sleep apnea, which is a physical condition in which the muscles of the throat ...

The FDA said the popular weight-loss drug should be combined with a reduced-calorie diet and increased physical activity. Obstructive sleep apnea happens ... But standard therapy with breathing ...

The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...